Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Hui-En Zhan"'
Autor:
Yan Jia, Wei Liu, Hui-En Zhan, Xiao-Ping Yi, Hui Liang, Qi-Li Zheng, Xin-Ya Jiang, Hai-Yan Zhou, Liang Zhao, Xie-Lan Zhao, Hui Zeng
Publikováno v:
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-5 (2020)
Abstract MicroRNAs (miRNAs) play important roles in cell proliferation, differentiation, and survival and may be useful for acute myeloid leukemia (AML) diagnosis and prognosis. In this study, we defined a novel miRNA, hsa-miR-12462, through small RN
Externí odkaz:
https://doaj.org/article/ebc9e50907be45668f4194f68c080a7c
Autor:
Wei Liu, Jin-Mou Yi, Yi Liu, Cong Chen, Kai-Xuan Zhang, Cheng Zhou, Hui-En Zhan, Liang Zhao, Stephanie Morales, Xie-Lan Zhao, Hui Zeng
Publikováno v:
Frontiers in Genetics, Vol 11 (2021)
Acute myeloid leukemia (AML) is a threatening hematological malignant disease in which new successful approaches in therapy are needed. Cyclin-dependent kinase 6 (CDK6), a regulatory enzyme of the cell cycle that plays an important role in leukemogen
Externí odkaz:
https://doaj.org/article/3364977b4b9c4497bc4054b28e69a84a
Publikováno v:
Blood Science. 1:44-49
Leukemia is a common hematological malignancy with overall poor prognosis. Novel therapies are needed to improve the outcome of leukemia patients. Cholesterol metabolism reprogramming is a featured alteration in leukemia. Many metabolic-related genes
Autor:
Xinya Jiang, Juan Du, Cheng Zhou, Hui-En Zhan, Peng Fang, Hui Liang, Jue Li, Hui Zeng, Yi Liu, Xuejun Xu, Qun He
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 137, Iss, Pp 111378-(2021)
Hydroxy-3-methylglutaryl-CoA synthase 1 (HMGCS1) is a key enzyme in the mevalonate pathway of cholesterol synthesis. Dysregulation of HMGCS1 expression is a common occurrence in many solid tumors. It was also found to be overexpressed in newly diagno
Autor:
Tianming Zhao, Hui Zeng, Hui Liang, Lilian Jin, Shurong Xie, Wei Liu, Yan Jia, Xin-Ya Jiang, Hui-Wen Wang, Hui-En Zhan
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Frontiers in Medicine
Frontiers in Medicine
The heterogeneous nature of acute myeloid leukemia (AML) and its poor prognosis necessitate therapeutic improvement. Current advances in AML research yield important insights regarding both AML genetics and epigenetics. MicroRNAs (miRNAs) play import
Autor:
Wei Liu, Xin-Ya Jiang, Hai-Yan Zhou, Liang Zhao, Yan Jia, Hui Liang, Hui-En Zhan, Hui Zeng, Qi-Li Zheng, Xie-Lan Zhao, Xiao-Ping Yi
Publikováno v:
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-5 (2020)
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-5 (2020)
MicroRNAs (miRNAs) play important roles in cell proliferation, differentiation, and survival and may be useful for acute myeloid leukemia (AML) diagnosis and prognosis. In this study, we defined a novel miRNA, hsa-miR-12462, through small RNA sequenc
Autor:
Jia, Yan, Liu, Wei, Hui-En Zhan, Yi, Xiao-Ping, Liang, Hui, Zheng, Qi-Li, Xin-Ya Jiang, Zhou, Hai-Yan, Zhao, Liang, Xie-Lan Zhao, Zeng, Hui
Additional file 1: Table S1. Patient information. Table S2. Demographic and AML - related features of the expression level of hsa-miR-12462
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26a47b292130decc16854fde3660dde8
Autor:
Jia, Yan, Liu, Wei, Hui-En Zhan, Yi, Xiao-Ping, Liang, Hui, Zheng, Qi-Li, Xin-Ya Jiang, Zhou, Hai-Yan, Zhao, Liang, Xie-Lan Zhao, Zeng, Hui
Additional file 4. Detailed materials and methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08c595bb3a52139c47605d6703199102
Autor:
Wen-Jin Li, Hui-En Zhan, Meng-Meng Zhang, Deng-Shu Wu, Fangping Chen, Fang-Fang Huang, Peng Fang, Hui Zeng, Peng-Fei Cao, Min-Yuan Peng, Jian Zhang
Publikováno v:
Cancer Letters. 357:297-306
Current valid treatments for acute myeloid leukemia (AML) include chemotherapy and hematopoietic stem cell transplantation, which are defective and limited respectively. The insulin-like growth factor 1 receptor (IGF-1R) is up-regulated in many solid
Autor:
Yan-Hui Yu, Deng-Shu Wu, Fang-Fang Huang, Zheng Zhang, Lin-Xin Liu, Jian Zhang, Hui-En Zhan, Min-Yuan Peng, Hui Zeng, Fang-Ping Chen
Publikováno v:
Stem Cell Research & Therapy; 2013, Vol. 4 Issue 5, p1-20, 20p